The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

@inproceedings{Moretti2012TheFS,
  title={The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers },
  author={Myla E. Moretti and Daniela L. Caprara and Irina Drehuta and Emily F Y Yeung and Stefanie Cheung and Lisa M Federico and Gideon Koren},
  booktitle={Obstetrics and gynecology international},
  year={2012}
}
Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are known to cause fetal renal damage in pregnancy. Due to conflicting reports in the literature, their safety after first trimester exposure has been debated. Our aim was to determine whether the use of ACE inhibitors or ARBs in the first trimester of pregnancy is associated with an increased risk for major malformations or other adverse outcomes. All subjects were prospectively enrolled from among women… CONTINUE READING
17 Extracted Citations
32 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 17 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 32 references

First trimester use of ACE-inhibitors and risk of major malformations

  • H. Malm, M. Artama, M. Gissler
  • Reproductive Toxicology, vol. 26, no. 1, p. 67…
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…